 |
62 Diseases |  |
27 Trials |
|
27 Trials |  |
847 News |  |
| «12345678910» |
- Lantus (insulin glargine) / Sanofi
Clinical: REACT4SENSOR: Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=10, Enrolling by invitation, Sponsor: Medical University of Graz
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial primary completion date: Levemir-Body Composition and Energy Metabolism (clinicaltrials.gov) - May 5, 2014
P4, N=42, Completed, Sponsor: Institut de Recherches Cliniques de Montreal
Trial primary completion date: Jul 2014 --> Apr 2014
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Levemir-Body Composition and Energy Metabolism (clinicaltrials.gov) - May 5, 2014
P4, N=42, Completed, Sponsor: Institut de Recherches Cliniques de Montreal
Trial primary completion date: Jul 2014 --> Apr 2014 N=80 --> 42
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Levemir-Body Composition and Energy Metabolism (clinicaltrials.gov) - May 5, 2014
P4, N=42, Completed, Sponsor: Institut de Recherches Cliniques de Montreal
N=80 --> 42 Recruiting --> Completed
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial, Combination therapy: A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin (clinicaltrials.gov) - May 4, 2014
P3, N=358, Not yet recruiting, Sponsor: Novo Nordisk A/S
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk, Fiasp (fast-acting insulin aspart) / Novo Nordisk
Enrollment closed, Combination therapy: Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes (clinicaltrials.gov) - Mar 9, 2014
P3, N=1095, Active, not recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: Action to Control Cardiovascular Risk in Diabetes (ACCORD) (clinicaltrials.gov) - Feb 6, 2014
P3, N=10251, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- metformin / Generic mfg.
Enrollment change: CIMT: The Copenhagen Insulin and Metformin Therapy Trial (clinicaltrials.gov) - Feb 1, 2014
P4, N=415, Completed, Sponsor: Steno Diabetes Center
Active, not recruiting --> Completed N=900 --> 415
- metformin / Generic mfg.
Trial completion: CIMT: The Copenhagen Insulin and Metformin Therapy Trial (clinicaltrials.gov) - Feb 1, 2014
P4, N=415, Completed, Sponsor: Steno Diabetes Center
N=900 --> 415 Active, not recruiting --> Completed
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk, Apidra (insulin glulisine) / Sanofi
New P4 trial: TRICIDIA: Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes (clinicaltrials.gov) - Jan 27, 2014
P4, N=60, Recruiting, Sponsor: Centre Hospitalier Universitaire Dijon
- |||||| Steglatro (ertugliflozin) / Pfizer, Merck (MSD)
Monotherapy: A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). (clinicaltrials.gov) - Jan 26, 2014
P3, N=600, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Steglatro (ertugliflozin) / Pfizer, Merck (MSD)
Monotherapy: A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). (clinicaltrials.gov) - Jan 9, 2014
P3, N=600, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes (clinicaltrials.gov) - Dec 9, 2013
P4, N=52, Completed, Sponsor: University Hospital, Toulouse
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Victoza (liraglutide) / Novo Nordisk
Enrollment closed: Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics (clinicaltrials.gov) - Nov 7, 2013
P4, N=36, Active, not recruiting, Sponsor: Mountain Diabetes and Endocrine Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Victoza (liraglutide) / Novo Nordisk, Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P4 trial: The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study (clinicaltrials.gov) - Oct 20, 2013
P4, N=100, Not yet recruiting, Sponsor: University of Texas Southwestern Medical Center
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk, DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
Enrollment open: A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Oct 16, 2013
P3, N=346, Recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment closed: The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (clinicaltrials.gov) - Aug 22, 2013
P3, N=280, Active, not recruiting, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||||| Tresiba (insulin degludec) / Novo Nordisk, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Jul 31, 2013
P3, N=350, Completed, Sponsor: Novo Nordisk
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment open: A Trial Comparing the Glycaemic Control of Levemir (clinicaltrials.gov) - Jun 24, 2013
P4, N=140, Recruiting, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P4 trial: A Trial Comparing the Glycaemic Control of Levemir (clinicaltrials.gov) - Jun 2, 2013
P4, N=140, Recruiting, Sponsor: Novo Nordisk A/S
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Clinical: Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy (clinicaltrials.gov) - Apr 21, 2013
P=N/A, N=94, Recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk, DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
New P3 trial: A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Apr 17, 2013
P3, N=346, Recruiting, Sponsor: Novo Nordisk A/S
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk, Fiasp (fast-acting insulin aspart) / Novo Nordisk
New P3 trial, Combination therapy: Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes (clinicaltrials.gov) - Apr 11, 2013
P3, N=1095, Active, not recruiting, Sponsor: Novo Nordisk A/S
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P4 trial: GlyCEDIA: Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients (clinicaltrials.gov) - Apr 9, 2013
P4, N=38, Completed, Sponsor: Centre Europeen d'Etude du Diabete
- Levemir (insulin detemir rDNA origin) / Novo Nordisk, NovoLog (insulin aspart) / Novo Nordisk
Trial completion, Compliance: INSUVASC: INSUlin Regimens and VASCular Functions (clinicaltrials.gov) - Feb 19, 2013
P=N/A, N=42, Completed, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: KILOS: Observational Study on Levemir (clinicaltrials.gov) - Jan 29, 2013
P=N/A, N=365, Completed, Sponsor: Novo Nordisk
Recruiting --> Completed Active, not recruiting --> Completed
- Symlin (pramlintide) / AstraZeneca, Byetta (exenatide) / AstraZeneca
Enrollment closed: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia (clinicaltrials.gov) - Jan 24, 2013
P4, N=35, Active, not recruiting, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial termination: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes (clinicaltrials.gov) - Dec 20, 2012
P4, N=58, Terminated, Sponsor: Novo Nordisk
Recruiting --> Active, not recruiting Completed --> Terminated; Trial terminated prematurely due to slow recruitment.
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment closed: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (clinicaltrials.gov) - Dec 16, 2012
P2, N=90, Active, not recruiting, Sponsor: University of Washington
Completed --> Terminated; Trial terminated prematurely due to slow recruitment. Recruiting --> Active, not recruiting
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days (clinicaltrials.gov) - Dec 16, 2012
P2, N=60, Completed, Sponsor: University of Washington
Recruiting --> Active, not recruiting Recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis (clinicaltrials.gov) - Dec 2, 2012
P3, N=19, Completed, Sponsor: University of Aarhus
Recruiting --> Completed Recruiting --> Completed
- ||||||| Bydureon (exenatide XR once-weekly) / AstraZeneca
Trial completion, Combination therapy: Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes (clinicaltrials.gov) - Nov 19, 2012
P3, N=222, Completed, Sponsor: Bristol-Myers Squibb
Recruiting --> Completed Active, not recruiting --> Completed
- Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial termination: Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine (clinicaltrials.gov) - Oct 30, 2012
P3, N=66, Terminated, Sponsor: University Hospital Tuebingen
Active, not recruiting --> Completed Recruiting --> Terminated
- Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine (clinicaltrials.gov) - Oct 30, 2012
P3, N=66, Terminated, Sponsor: University Hospital Tuebingen
Recruiting --> Terminated N=160 --> 66
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes (clinicaltrials.gov) - Oct 16, 2012
P4, N=58, Terminated, Sponsor: Novo Nordisk
N=160 --> 66 N=230 --> 58
- |||||||||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial: PREDICTIVE (clinicaltrials.gov) - Oct 16, 2012
P3, N=2287, Completed, Sponsor: Novo Nordisk
- ||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment open: Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy (clinicaltrials.gov) - Oct 1, 2012
P=N/A, N=60, Enrolling by invitation, Sponsor: University of Colorado, Denver
N=230 --> 58 Not yet recruiting --> Enrolling by invitation
- |||||||||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial: Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes (clinicaltrials.gov) - Sep 30, 2012
P3, N=131, Completed, Sponsor: Novo Nordisk
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes (clinicaltrials.gov) - Aug 30, 2012
P4, N=40, Completed, Sponsor: Lise Tarnow
Not yet recruiting --> Enrolling by invitation N=100 --> 40
- ||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Insulin Analogues and Severe Hypoglycaemia (clinicaltrials.gov) - Aug 30, 2012
P4, N=179, Completed, Sponsor: Lise Tarnow
N=100 --> 40 N=370 --> 179
- |||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Insulin Analogues and Severe Hypoglycaemia (clinicaltrials.gov) - Aug 30, 2012
P4, N=179, Completed, Sponsor: Lise Tarnow
N=370 --> 179 Active, not recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes (clinicaltrials.gov) - Aug 12, 2012
P=N/A, N=64, Completed, Sponsor: Ankara University
Active, not recruiting --> Completed Recruiting --> Completed
- Victoza (liraglutide) / Novo Nordisk
New P4 trial: Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics (clinicaltrials.gov) - Jul 29, 2012
P4, N=36, Active, not recruiting, Sponsor: Mountain Diabetes and Endocrine Center
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: HA-BOT: Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment (clinicaltrials.gov) - Jun 27, 2012
P=N/A, N=1032, Completed, Sponsor: Novo Nordisk
Recruiting --> Completed N=500 --> 1032
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial initiation date: Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis (clinicaltrials.gov) - Jun 17, 2012
P3, N=19, Completed, Sponsor: University of Aarhus
N=500 --> 1032 Initiation date: Oct 2011 --> Feb 2012
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial: The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (clinicaltrials.gov) - Jun 10, 2012
P3, N=280, Active, not recruiting, Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
- |||| Jardiance (empagliflozin) / Eli Lilly, Boehringer Ingelheim
Combination therapy: Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes (clinicaltrials.gov) - May 29, 2012
P2b, N=494, Completed, Sponsor: Boehringer Ingelheim
Initiation date: Oct 2011 --> Feb 2012 Active, not recruiting --> Completed
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P2 trial: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (clinicaltrials.gov) - May 8, 2012
P2, N=90, Active, not recruiting, Sponsor: University of Washington
- |||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Full STEP: Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen (clinicaltrials.gov) - Apr 25, 2012
P4, N=401, Completed, Sponsor: Novo Nordisk
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes (clinicaltrials.gov) - Apr 25, 2012
P4, N=30, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed Recruiting --> Completed